Sclerostin Regulation of Skeletal Mineralization and Phosphate Metabolism
Sclerostin Regulation of Skeletal Mineralization and Phosphate Metabolism
批准号:
10240577
负责人:
Ryan Dee Ross
金额:
$12.49万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-08-31
关键词:
AdolescentAdultAnimal ModelAntibodiesBiochemicalBone MatrixCalcitriolCell Culture TechniquesCell LineCellular biologyClinical PathologyDataDefectDiseaseEndocrinologyEndopeptidasesExcretory functionFamilial hypophosphatemic bone diseaseFundingGene ExpressionGene ProteinsGenesGeneticGoalsHeritabilityHomologous GeneHormonesHypophosphatemiaIn VitroInorganic Phosphate TransporterKidneyKineticsLaboratory ResearchLeadLinkMentorsMetabolismMineralsModelingMolecularMolecular BiologyMusMutationOsteocytesOsteogenesisOsteomalaciaOsteoporosisPathologicPathway AnalysisPathway interactionsPatientsPharmacologic SubstancePhysiologic calcificationProductionProteinsPublicationsPublishingRegulationReportingResearchResearch PersonnelResidual stateRicketsRoleSerumSkeletal DevelopmentSuggestionTechniquesTestingTrainingTransgenic AnimalsTranslational ResearchVitamin DWNT Signaling Pathwaybasebeta cateninbonebone massbone strengthconditional knockoutfibroblast growth factor 23in vivoin vivo Modelinhibitor/antagonistinorganic phosphateinterestmRNA Expressionmineralizationmouse modelnovelnovel therapeuticsoverexpressionpre-clinicalpromoterresponseskeletaltooltreatment strategyurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
X-linked hypophosphatemia (XLH) is the most common form of heritable Rickets. Patients with XLH present
with two related clinical pathologies; defective bone matrix mineralization and hypophosphatemia. The
mineralization defect is primarily caused by the accumulation of mineralization inhibitors within the bone matrix,
while hypophosphatemia is attributed to increased circulating levels of the phosphate-regulating hormone,
fibroblast growth factor 23 (FGF23). Although the mutation that causes XLH has been identified as the
phosphate-regulating endopeptidase homologue, X-linked (PHEX) gene, the factors that ultimately lead to poor
mineralization and elevated FGF23 are not well described. My preliminary data implicates the protein sclerostin
in both skeletal mineralization and phosphate metabolism regulation. The current proposal will test the
hypothesis that sclerostin is a key regulator of skeletal mineralization and phosphate metabolism using both
mechanistic and translational research aims. Aim 1 will investigate potential mechanisms of action using both
in vitro and in vivo models while Aim 2 will test the use of Scl-Ab as a treatment option for XLH using the Hyp
mouse model of XLH. My long-term goal is to become a leading independent researcher in the field of skeletal
mineralization and mineral metabolism. In order to achieve these goals, I have chosen successful researchers
to serve as mentors, including Dr. Anne George (primary mentor), an expert in skeletal mineralization, and Dr.
Di Chen (co-mentor), an expert in skeletal development and Wnt signaling. The research described will serve
as an ideal training vehicle for me to develop expertise in the use of cell culture and transgenic animal models,
while also furthering my understanding of the systemic control of mineral metabolism. The training plan will
focus on cell and molecular biology, endocrinology and the systemic control of mineral metabolism, and
advanced training in grantsmanship, which will give me the tools necessary to build a successful independent
research laboratory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying the long-term metabolic complications of in-utero and lactational antiretroviral exposure
-
批准号:10762179
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2023
-
负责人:Ryan Dee Ross
-
依托单位:
Bone and fat cross-talk in antiretroviral therapy (ART) treated HIV patients
-
批准号:10548410
-
项目类别:
-
资助金额:$41.78万
-
财政年份:2022
-
负责人:Ryan Dee Ross
-
依托单位:
Bone and fat cross-talk in antiretroviral therapy (ART) treated HIV patients
-
批准号:10856307
-
项目类别:
-
资助金额:$17.56万
-
财政年份:2022
-
负责人:Ryan Dee Ross
-
依托单位:
Assessing the function role of sclerostin in periodontal disease in XLH
-
批准号:10303753
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2021
-
负责人:Ryan Dee Ross
-
依托单位:
Characterization of a humanized mouse model to study HIV and ARV effects on bone
-
批准号:10324198
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2021
-
负责人:Ryan Dee Ross
-
依托单位:
Assessing the function role of sclerostin in periodontal disease in XLH
-
批准号:10454382
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2021
-
负责人:Ryan Dee Ross
-
依托单位:
Sclerostin Regulation of Skeletal Mineralization and Phosphate Metabolism
-
批准号:10457434
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2019
-
负责人:Ryan Dee Ross
-
依托单位:
海外基金